C-Reveal Therapeutics

Deal To Watch
BETA

C-Reveal’s proprietary technology helps the body’s natural immune system to identify and kill cancer cells.

Analytics

Raised to Date: $710,470

Aggregate Commitments $
Platform

Netcapital

Start Date

01/28/2021

Close Date

04/16/2021

Min. Goal

$10,000

Max. Goal

$1,070,000

Min. Investment

$100

Security Type

Equity - Common

Funding Type

RegCF / RegD 506(C)

Series

Pre-Seed

Pre-Money Valuation

$10,000,000

Weekly Commitments $
Status

Active

Reporting Date

02/24/2021

Days Remaining

50

% of Min. Goal

7,105%

% of Max. Goal

66%

Likelihood of Max
Avg. Daily Raise

$26,314

Momentum
Location

Pembroke, Massachusetts

Industry

Healthcare & Pharmaceuticals

Tech Sector

HealthTech

Distribution Model

B2B

Margin

High

Capital Intensity

High

Business Type

Growth

C-Reveal Therapeutics, with a post-money valuation of $13.25 million, is raising crowdfunding on NetCapital. The company has identified two key cancer-specific enzymes that, when inhibited, reveal hidden tumors to the immune system. C-Reveal plans to develop inhibitors for these enzymes, which will enable the immune system to recognize, target, and attack cancer cells. They will also allow existing cancer immunotherapies to work in a greater number of patients. The company was founded by Thomas Haag, Ph.D., J.D., Mark Cobbold, M.D., Ph.D., Keith Flaherty, M.D., and Cyril Benes, Ph.D. The current round of crowdfunding has a minimum goal of $10,000 and a maximum goal of $1,070,000, and the proceeds will be used for new patents, R&D, hiring, marketing, and operating expenses. C-Reveal is partnering with Evotec, a European-based contract research organization, for the next step in our drug discovery process.

Summary of Crowdfunding Raises
Close Date Platform Valuation/Cap Total Raised Security Type Status Reg Type
04/16/2021 Netcapital $10,000,000 $710,470 Equity - Common Active RegCF
01/27/2021 Netcapital $10,000,000 $0 Equity - Common Confirmed Closed Test the Waters

Ratings

last updated 02/25/2021

Ratings Platform - Beta Trial

Our new ratings and analytics platform is currently in Beta. To gain access to the Beta platform features, upgrade to a Pro paid account and accept the Beta terms on any page.

For a limited time, use coupon code "TRYMERLIN20" for a free 20 day trial of Kingscrowd Pro and Merlin Beta. Your paid subscription will activate at the end of 20 days. Cancel anytime.

Analyst Report

Deal To Watch
Ratings Platform - Beta Trial

Our new ratings and analytics platform is currently in Beta. To gain access to the Beta platform features, upgrade to a Pro paid account and accept the Beta terms on any page.

For a limited time, use coupon code "TRYMERLIN20" for a free 20 day trial of Kingscrowd Pro and Merlin Beta. Your paid subscription will activate at the end of 20 days. Cancel anytime.
Other Deals

MedVector on StartEngine

The COVID-19 pandemic has grown the telehealth industry exponentially. A recent study of U.S medical specialists found that

Crowd
Phoenix PharmaLabs on Netcapital

In the years before the world’s current COVID-19 crisis, America in particular faced a deadly and persistent threat…

Crowd
Millennial Fertility Co. on NetCapital

The Millennial Fertility Co. team has been selected as a “Deal to Watch” by KingsCrowd. This distinction is…

Crowd
Create your first portfolio
WELCOME TO YOUR OWN INVESTMENTS PORTFOLIO ON KINGSCROWD.

Now you can track all of your startup investments in one place utilizing our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Add C-Reveal Therapeutics on NetCapital
Follow company
Follow C-Reveal Therapeutics on NetCapital